ReviewFrontiers in pharmacology2026
The multifaceted role of ATM protein in neural stem/progenitor cell biology and neurogenesis: beyond DNA damage response.
Review in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Ataxia Telangiectasia Mutated (ATM) protein kinase is a well recognized master regulator of the DNA damage response (DDR) and cell cycle control whose dysfunction leads to the rare neurological disorder Ataxia Telangiectasia (AT). A mounting body of evidence has revealed unequivocally that ATM relevance extends far beyond its DDR role and includes critical non-canonical functions. This minireview summarizes the current knowledge on ATM role in neural stem progenitor cell (NSPC) biology and in neurogenesis. In particular, herein we highlight how ATM is crucial for NSPC proliferation, differentiation, and survival, acting not only as a guardian of genomic integrity but also as a key orchestrator of developmental timing. Furthermore, we discuss how ATM deficiency in AT leads to dysregulated NSPC proliferation, premature neuronal maturation, and impaired quality control during neurogenesis, potentially contributing to progressive neurodegeneration and complex neurological symptoms associated with this pediatric disorder. By integrating canonical and non-canonical mechanisms, this review may offer a more comprehensive understanding of ATM key role in maintaining brain homeostasis integrity from the stem cell level. Moreover, it adds a more complex perspective on AT pathogenesis and opens novel avenues for future therapeutic interventions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.